PositiveID Corporation (OTCQB: PSID) is an emerging growth company that develops biological detection and diagnostic systems for America's homeland defense and the global healthcare market. PositiveID specializes in microfluidic systems for the automated preparation and performance of biological assays in order to detect biological threats and outbreaks whether airborne, in a healthcare setting, or at the point of need.
Oct 25, 2016
PositiveID's Chief Technology Advisor Chairs Healthcare Innovation Panel at National Defense Industrial Association Health Affairs Biodefense Summit
Oct 24, 2016
PositiveID's Caregiver Average Monthly Sales Increase by 60% Among Customers Participating in National Group Buy Program